Periodic Reporting for period 2 - Hemstem (Targeting leukaemia by modulating hematopoietic stem cell competitiveness)

The outlook for patients with acute myeloid leukemia has improved over the past years but still more than half of younger adults and about 90% of elderly patients diagnosed with AML die from the disease. Disease relapse is a main cause of death, and hematopoietic stem cell...